Rohto Pharmaceutical has decided to pay an end-of-term dividend of 25 yen per share for the fiscal year ending March 2026, with a total amount of 5,649 million yen. The dividend will be effective from June 8, 2026, representing an increase from the previous year.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4527","jir_company_name":"Rohto Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-21","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4527-20260521-01.pdf","jir_short_summary":"Rohto Pharmaceutical has decided to pay an end-of-term dividend of 25 yen per share for the fiscal year ending March 2026, with a total amount of 5,649 million yen. The dividend will be effective from June 8, 2026, representing an increase from the previous year.","jir_summary":"### Dividend Decision and Details\nRohto Pharmaceutical has decided to pay a dividend of 25 yen per share for the fiscal year ending March 2026, with a total amount of 5,649 million yen. The dividend will be effective from June 8, 2026, representing an increase from the previous year's 20 yen. The increase in dividends indicates a strengthening of shareholder returns, utilizing retained earnings as the source.\n\n### Future Shareholder Returns and Outlook\nThe increase in dividend reflects a commitment to stronger shareholder returns. While future forecasts and outlook are not detailed in the material, there is an indication of continued stable and increased dividends. Investors may focus on the company's stable dividend policy and ongoing shareholder return initiatives.","jir_financial_highlights":"Dividend per Share at Year-End: 25 yen (YoY +5 yen (20 yen \u2192 25 yen))\nTotal Dividend Payment: 5,649 million yen (YoY +1,130 million yen (4,519 million yen \u2192 5,649 million yen))\nDividend Payment Date: June 8, 2026 (Unknown)","jir_category":"","jir_hashtags":"#RohtoPharmaceutical, #Dividend, #JapanStocks","jir_key_figures":"Total Dividend Payment: 5,649 million yen\nDividend per Share: 25 yen\nDividend Payment Date: June 8, 2026","jir_meta_title":"\u3010Rohto Pharmaceutical\u3011Dividend Increased to 25 Yen\uff5cMay 2026","jir_meta_description":"Rohto Pharmaceutical has decided to pay a dividend of 25 yen per share for fiscal year ending March 2026, with a total of 5,649 million yen. Effective from June 8, 2026, strengthening shareholder returns.","jir_og_title":"\u3010Rohto Pharmaceutical\u3011Dividend Increase\uff5cMay 2026","jir_og_description":"Rohto Pharmaceutical increases its dividend for fiscal year ending March 2026, enhancing shareholder returns. The dividend is 25 yen, totaling 5,649 million yen.","jir_og_image_url":"","jir_chart_data_collection":"","ir_related_company":7770,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"dividend","footnotes":""},"sector":[],"importance":[],"class_list":["post-53620","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n